Côd QR

Isoalantolactone induces apoptosis of non-small cell lung cancer cells by targeting EGFR and MET kinases and ROS generation

Extensive research efforts are necessary to develop effective treatments for non-small cell lung cancer (NSCLC), one of the most lethal malignancies. To address limitations of gefitinib (GEF) in NSCLC treatment, we investigated the anticancer activity of isoalantolactone (IAL) in HCC827 cells with o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Na Yeong Lee, A-Young Nam, Goo Yoon, Jin Woo Park, Yung Hyun Choi, Joon-Seok Choi, Sang Hoon Joo, Jung-Hyun Shim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2026-03-01
Cyfres:Heliyon
Pynciau:
Isoalantolactone
Non-small cell lung cancer
EGFR
MET
Cell cycle
Reactive oxygen species
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2405844026000538
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg